Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
Clinical trial NCT02238496 · COMPLETED
Trial details
- NCT number
- NCT02238496
- Sponsor
- Andrew B Lassman, MD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-08
- Primary completion
- 2017-10-27
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.